|
GTF3C3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.319200E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.060200E-01 |
| Normal-vs-Stage2 |
6.119600E-02 |
| Normal-vs-Stage3 |
6.796000E-02 |
| Normal-vs-Stage4 |
2.688400E-01 |
| Stage1-vs-Stage2 |
1.101850E-01 |
| Stage1-vs-Stage3 |
1.718410E-01 |
| Stage1-vs-Stage4 |
4.635000E-01 |
| Stage2-vs-Stage3 |
7.366200E-01 |
| Stage2-vs-Stage4 |
6.874600E-01 |
| Stage3-vs-Stage4 |
8.811800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.814110E-02 |
| Normal-vs-AfricanAmerican |
1.522960E-01 |
| Normal-vs-Asian |
6.205000E-01 |
| Caucasian-vs-AfricanAmerican |
8.791000E-01 |
| Caucasian-vs-Asian |
9.484600E-01 |
| AfricanAmerican-vs-Asian |
9.906000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.123800E-01 |
| Normal-vs-Female |
3.61560000000649E-05 |
| Male-vs-Female |
7.87590000000948E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.999800E-01 |
| Normal-vs-Extreme_Weight |
5.491600E-01 |
| Normal-vs-Obese |
1.384220E-02 |
| Normal-vs-Extreme_Obese |
7.190600E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.053000E-01 |
| Normal_Weight-vs-Obese |
1.763380E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.400400E-01 |
| Extreme_Weight-vs-Obese |
7.144800E-03 |
| Extreme_Weight-vs-Extreme_Obese |
5.092400E-01 |
| Obese-vs-Extreme_Obese |
4.937000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.685720E-02 |
| Normal-vs-Age(41-60Yrs) |
3.538200E-03 |
| Normal-vs-Age(61-80Yrs) |
3.236200E-01 |
| Normal-vs-Age(81-100Yrs) |
9.101400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.205020E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.566500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.634200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.260500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.184200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.549600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.898390E-01 |
| Normal-VS-Type2 PRCC |
5.591600E-02 |
| Normal-VS-KIRP CIMP |
2.244000E-02 |
| Normal-VS-Unclassified PRCC |
3.177600E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.683800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.256700E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.142810E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.670400E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.140800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.953780E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.816200E-01 |
| Normal-vs-N1 |
4.603600E-03 |
| Normal-vs-N2 |
5.115200E-01 |
| N0-vs-N1 |
5.564100E-03 |
| N0-vs-N2 |
3.628000E-01 |
| N1-vs-N2 |
5.156400E-01 |
|
|
